Shareholders' Equity (Details) - USD ($) $ / shares in Units, $ in Millions |
3 Months Ended | ||||
---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 24, 2025 |
Mar. 31, 2025 |
Apr. 30, 2024 |
Sep. 19, 2022 |
|
Stock Repurchase Program [Member] | |||||
Shareholders' Equity [Abstract] | |||||
Common stock repurchase authorized amount | $ 1,500.0 | $ 500.0 | $ 1,500.0 | ||
Number of shares repurchased (in Shares) | 20,269,450 | 57,110,703 | |||
Aggregate purchase price | $ 208.3 | $ 644.8 | |||
Stock purchases | 0.0 | ||||
Stock Repurchase Program [Member] | Sumitomo Pharma Co. Ltd. [Member] | |||||
Shareholders' Equity [Abstract] | |||||
Number of shares repurchased (in Shares) | 71,251,083 | ||||
Share price (in Dollars per share) | $ 9.1 | ||||
Aggregate purchase price | $ 648.4 | ||||
At-the-Market Equity Offering Program [Member] | Cowen [Member] | |||||
Shareholders' Equity [Abstract] | |||||
Common shares aggregate offering price authorized | $ 400.0 | ||||
Common shares aggregate offering price authorized, remaining capacity available | $ 400.0 |
X | ||||||||||
- Definition This represent the aggregate equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. No definition available.
|
X | ||||||||||
- Definition The common shares aggregate offering price authorized remaining capacity to issue under equity offering program. No definition available.
|
X | ||||||||||
- Definition The common shares aggregate offering price authorized to issue under equity offering program. No definition available.
|
X | ||||||||||
- Definition This represents the number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. No definition available.
|
X | ||||||||||
- Definition Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
X | ||||||||||
- Definition Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|